|
FAM173A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.44089209850063E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.53619389115556E-13 |
| Normal-vs-Stage2 |
4.437100E-03 |
| Normal-vs-Stage3 |
4.39620000000085E-05 |
| Normal-vs-Stage4 |
1.112020E-01 |
| Stage1-vs-Stage2 |
1.260440E-01 |
| Stage1-vs-Stage3 |
4.356200E-02 |
| Stage1-vs-Stage4 |
4.628100E-04 |
| Stage2-vs-Stage3 |
9.830400E-01 |
| Stage2-vs-Stage4 |
1.668640E-01 |
| Stage3-vs-Stage4 |
7.368000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62470037423645E-12 |
| Normal-vs-AfricanAmerican |
8.25870000000783E-05 |
| Normal-vs-Asian |
2.680200E-01 |
| Caucasian-vs-AfricanAmerican |
3.246600E-01 |
| Caucasian-vs-Asian |
4.811400E-01 |
| AfricanAmerican-vs-Asian |
8.121400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
5.95669999999826E-05 |
| Male-vs-Female |
3.167900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.87230000000228E-05 |
| Normal-vs-Extreme_Weight |
1.66933133982639E-12 |
| Normal-vs-Obese |
1.61570000045685E-07 |
| Normal-vs-Extreme_Obese |
1.237510E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.272050E-02 |
| Normal_Weight-vs-Obese |
5.511000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.033400E-01 |
| Extreme_Weight-vs-Obese |
3.262000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.315800E-01 |
| Obese-vs-Extreme_Obese |
5.047800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.774090E-02 |
| Normal-vs-Age(41-60Yrs) |
1.37080002904355E-09 |
| Normal-vs-Age(61-80Yrs) |
1.63491442606301E-12 |
| Normal-vs-Age(81-100Yrs) |
3.804700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.016600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.793600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.879400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.343200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.305000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.644400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.151250E-04 |
| Normal-VS-KIRP CIMP |
6.207000E-01 |
| Normal-VS-Unclassified PRCC |
2.393200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.369200E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.838000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.262000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.687190E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.494430E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.560900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.17869999982645E-07 |
| Normal-vs-N1 |
1.375550E-02 |
| Normal-vs-N2 |
9.493900E-02 |
| N0-vs-N1 |
8.739500E-02 |
| N0-vs-N2 |
3.616500E-03 |
| N1-vs-N2 |
4.131600E-01 |
|
|
